FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

332347007: Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3693212013 Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3693213015 Product containing precisely erythromycin 40 milligram/1 milliliter and zinc acetate 12 milligram/1 milliliter conventional release cutaneous solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Is a Product containing erythromycin in topical dosage form false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Erythromycin (substance) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Is a Product containing erythromycin and zinc acetate (medicinal product) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc acetate (substance) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Zinc false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has manufactured dose form forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has manufactured dose form Drug solution false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has manufactured dose form Cutaneous solution true Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Is a Product containing zinc acetate in topical dosage form false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength denominator value un false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength denominator value un false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Count of base of active ingredient deux false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Erythromycin (substance) false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Zinc acetate (substance) false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength numerator value douze false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Zinc acetate (substance) false Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Erythromycin (substance) false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Has concentration strength numerator value 40 false Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Is a Erythromycin and zinc acetate only product in cutaneous dose form true Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Erythromycin (substance) true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Erythromycin (substance) true Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Zinc acetate (substance) true Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Zinc acetate (substance) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

GB English

US English

Back to Start